A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

ClinicalTrials.gov ID: NCT00044226

Public ClinicalTrials.gov record NCT00044226. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Dosing Regimens of ML-04A in Subjects With Symptomatic Benign Prostatic Hyperplasia

Study identification

NCT ID: NCT00044226
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Milkhaus Laboratory; Industry
Enrollment: 350 participants

Conditions and interventions

Conditions

Prostatic Hyperplasia

Interventions

ML-04A Drug

Drug

Eligibility (public fields only)

Age range: 45 Years to 80 Years
Sex: Male
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 31, 2002
Primary completion: Not listed
Completion: Sep 30, 2002
Last update posted: Jun 23, 2005

2002

United States locations

U.S. sites: 14
U.S. states: 11
U.S. cities: 14

Facility	City	State	ZIP	Site status
Charles White, MD	Mobile	Alabama	36608	Recruiting
Douglas Young, MD	Fair Oaks	California	95628	Recruiting
Rodney Anderson, MD	Stanford	California	94305	Recruiting
Eugene Dula, MD	Van Nuys	California	91405	Recruiting
Joel Kaufman, MD	Aurora	Colorado	80012	Recruiting
Donald Bergner, MD	Clearwater	Florida	33761	Recruiting
Ira Klimberg, MD	Ocala	Florida	34474	Recruiting
Gary Friedlander, MD	Rockville	Maryland	20850	Recruiting
Sheldon Freedman, MD	Las Vegas	Nevada	89109	Recruiting
Edward Loizides, MD	Bay Shore	New York	11706	Recruiting
Richard Landau, MD	Sellersville	Pennsylvania	18960	Recruiting
H. Pat Hezmall, MD	Fort Worth	Texas	73104	Recruiting
Michael Godschalk, MD	Richmond	Virginia	23249	Recruiting
Roger Fincher, MD	Spokane	Washington	99202	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00044226, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 23, 2005 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00044226 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →